PEPG Stock Summary and Trading Ideas (Pepgen | NASDAQ:PEPG)

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

Pepgen trades on the NASDAQ stock market under the symbol PEPG.

As of March 5, 2026, PEPG stock price declined to $5.51 with 3,061,042 million shares trading.

PEPG has a beta of 0.99, meaning it tends to be less sensitive to market movements. PEPG has a correlation of 0.01 to the broad based SPY ETF.

PEPG has a market cap of $378.40 million. This is considered a Small Cap stock.

In the last 3 years, PEPG traded as high as $20.00 and as low as $.88.

The top ETF exchange traded funds that PEPG belongs to (by Net Assets): VTI, IBB, VXF, IWC, AVSC.

PEPG has outperformed the market in the last year with a return of +141.4%, while the SPY ETF gained +19.4%. In the last 3 month period, PEPG beat the market returning +3.7%, while SPY returned -0.2%. However, in the most recent 2 weeks PEPG has underperformed the stock market by returning -15.8%, while SPY returned -0.7%.

PEPG support price is $6.27 and resistance is $7.25 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PEPG shares will trade within this expected range on the day.